Chemtrade Logistics Income Fund Earnings Call Transcripts
Fiscal Year 2025
-
2025 delivered record results, though margin pressures from sulphur costs impacted SWC. Caustic soda prices are currently weak but expected to recover in the second half of 2026, while segment performance remains strong with ongoing investments and maintenance plans.
-
Record Q3 EBITDA and double-digit revenue growth were driven by strong segment performance and pricing power. 2025 guidance was raised, with only chlorine expected to contract in Q4, while growth investments and acquisitions support long-term targets.
-
Q2 2025 saw double-digit growth in revenue, EBITDA, and distributable cash, with strong segment performance and disciplined capital allocation. Updated 2025 guidance was raised, and the Polytec acquisition is set to expand water treatment offerings.
-
Q1 2025 saw double-digit revenue and EBITDA growth, led by the SWC segment, with strong cash flow supporting increased distributions and significant unit buybacks. Guidance was raised, and Vision 2030 targets 5%-10% annual EBITDA growth, driven by organic projects and strategic acquisitions.
Fiscal Year 2024
-
Reported strong 2024 results with CAD 1.79B revenue and CAD 470.8M EBITDA, driven by water chemicals and chlor-alkali growth. 2025 guidance targets CAD 430–460M EBITDA, with continued focus on capital returns, growth investments, and prudent balance sheet management.
-
Q3 2024 results showed resilient performance with stable revenue and a 1.9% EBITDA increase year-over-year, despite rail disruptions and a tough comparison to last year’s record quarter. Updated 2024 EBITDA guidance is CAD 445–460 million, with strong cash flow supporting growth and distributions.
-
Q2 2024 results exceeded expectations, prompting a guidance raise for full-year EBITDA to CAD 430–460 million. Water chemicals drove margin growth, while EC faced lower caustic soda prices. Capital allocation remains disciplined, with strong liquidity and active buybacks.